2-cyano-1-(2-((3-fluorobenzyl)oxy)ethyl)-3-methylguanidine

ID: ALA5180337

Chembl Id: CHEMBL5180337

PubChem CID: 168276730

Max Phase: Preclinical

Molecular Formula: C12H15FN4O

Molecular Weight: 250.28

Names and Identifiers

Canonical SMILES:  CN/C(=N\C#N)NCCOCc1cccc(F)c1

Standard InChI:  InChI=1S/C12H15FN4O/c1-15-12(17-9-14)16-5-6-18-8-10-3-2-4-11(13)7-10/h2-4,7H,5-6,8H2,1H3,(H2,15,16,17)

Standard InChI Key:  MATCNFJVWIOKTC-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5180337

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 250.28

Molecular Weight (Monoisotopic): 250.1230

AlogP: 0.99

#Rotatable Bonds: 5

Polar Surface Area: 69.44

Molecular Species: NEUTRAL

HBA: 3

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: 1.34

CX LogD: 1.34

Aromatic Rings: 1

Heavy Atoms: 18

QED Weighted: 0.35

Np Likeness Score: -1.83

References

1. Shinya S, Kawai K, Kobayashi N, Karuo Y, Tarui A, Sato K, Otsuka M, Omote M..  (2022)  Fluorophenylalkyl-substituted cyanoguanidine derivatives as bacteria-selective MATE transporter inhibitors for the treatment of antibiotic-resistant infections.,  74  [PMID:36215813] [10.1016/j.bmc.2022.117042]

Source

Source(1):

• Scientific Literature